About Us

360° of Immuno-oncology Insight Delivers Clarity for Decision-making

Since our founding in 2015, Veracyte has focused on translating the new understanding of the impact of immunity on cancer to develop innovatives services and products that resolve unmet medical needs. By combining cutting edge molecular biology, bioinformatics, and artificial intelligence technologies with the latest immuno-oncology science, we convert complex immune monitoring data into actionable insights that clarify decision-making.

Who We Are

Veracyte is an immuno-oncology diagnostic company providing oncologists and drug development organizations with first-in-class Immune-based diagnostic products and services to guide cancer care and contribute to precision medicine in the era of immuno-oncology and combination therapies.

Hour headquarters and research laboratories are located in the heart of Marseille Immunopôle - Luminy, near research institutions and platforms in immunology, research centers, and oncology care, and numerous biotechnology companies.

map@2x
icons-patients (2)

100+

Patients tested/week

icons-biopharma

40

Biopharma partners

icons-scientific-publications

27

Scientific publications

d-2-a-7535@2x

Dr Jerome Galon

Jerome Galon is a co-founder of Veracyte and the Chairman of its Scientific Advisory Board.

Winner for the European Inventor Award 2019 for Immunoscore®, Dr Jérôme Galon is Research Director (first class) at Inserm and head of an Inserm laboratory (Integrative Cancer Immunology) at the Cordeliers Research Center in Paris, France.

logo
logo-words

Our Mission

At Veracyte, our mission is to translate the tumor immune response into actionable insight that improves patient care and enhances the quality of life.

images-mission@2x

Join Our Team

Leadership Team